🇺🇸 FDA
Patent

US 10729736

Composition for reducing blood lipid and use thereof as healthcare dietary supplements

granted A61KA61K31/202A61K31/575

Quick answer

US patent 10729736 (Composition for reducing blood lipid and use thereof as healthcare dietary supplements) held by INFINITUS (CHINA) COMPANY LTD. expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INFINITUS (CHINA) COMPANY LTD.
Grant date
Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/202, A61K31/575, A61K35/60, A61K36/55